Malignancies following long‐term azathioprine treatment in chronic liver disease
- 1 April 1987
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 7 (2), 81-83
- https://doi.org/10.1111/j.1600-0676.1987.tb00321.x
Abstract
— One hundred and fifty-four patients with histologically verified nonalcoholic chronic liver disease were randomized to azathioprine or prednisone treatment. After a median of 91 months observation time, the cause of death was assessed retrospectively. Autopsy was performed in 82% of 71 deaths. In the azathioprine group 33% (13/39) died from malignant neoplasia, and in the prednisone group (13%) (4/32) (p = 0.08). Considering a possible fatal outcome as a consequence of treatment, this finding urges caution in the long-term application of azathioprine at the usual dose level.Keywords
This publication has 8 references indexed in Scilit:
- Main Causes of Death in CirrhosisScandinavian Journal of Gastroenterology, 1983
- Azathioprine and Subacute Myelomonocytic LeukemiaActa Medica Scandinavica, 1980
- Antineoplastic agents and the liverGastroenterology, 1980
- Extrahepatic Malignancy in Chronic Liver Disease: Report of Six CasesGastroenterology, 1976
- Chemical immunosuppression and human cancerCancer, 1974